Form 4 for BRTX BioRestorative Therapies, Inc.
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0001567619-22-012010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-01 | 2022-05-27 | BRTX | Broadrick Dale | 10% | P - Purchase | $3.61 | +11.0K | 268.3K | +4% | +$39.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | P | A | 10,957 | $3.61 | 268,260 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $3.3499 to $3.7999 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. |